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Summary
Loss of SURF1, a Complex IV assembly protein, was reported to increase lifespan in
mice despite dramatically lower cytochrome oxidase (COX) activity. Consistent with
this, our previous studies found advantageous changes in metabolism (reduced adi-
posity, increased insulin sensitivity, and mitochondrial biogenesis) in Surf1/ mice.
The lack of deleterious phenotypes in Surf1/ mice is contrary to the hypothesis
that mitochondrial dysfunction contributes to aging. We found only a modest (non-
significant) extension of lifespan (7% median, 16% maximum) and no change in
healthspan indices in Surf1/ vs. Surf1+/+ mice despite substantial decreases in
COX activity (22%–87% across tissues). Dietary restriction (DR) increased median
lifespan in both Surf1+/+ and Surf1/ mice (36% and 19%, respectively). We mea-
sured gene expression, metabolites, and targeted expression of key metabolic pro-
teins in adipose tissue, liver, and brain in Surf1+/+ and Surf1/ mice. Gene
expression was differentially regulated in a tissue-specific manner. Many proteins
and metabolites are downregulated in Surf1/ adipose tissue and reversed by DR,
while in brain, most metabolites that changed were elevated in Surf1/ mice.
Finally, mitochondrial unfolded protein response (UPRmt)-associated proteins were
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not uniformly altered by age or genotype, suggesting the UPRmt is not a key player
in aging or in response to reduced COX activity. While the changes in gene expres-
sion and metabolism may represent compensatory responses to mitochondrial
stress, the important outcome of this study is that lifespan and healthspan are not
compromised in Surf1/ mice, suggesting that not all mitochondrial deficiencies are
a critical determinant of lifespan.
K E YWORD S
cytochrome c oxidase, dietary restriction, lifespan, mitochondria, SURF1, mitochondrial
unfolded protein response
1 | INTRODUCTION
It has been proposed that compromised mitochondrial function is a
causal determinant of aging and age-related disease. While this is a
reasonable assumption, the data to support a universal direct link
between reduced mitochondrial function and lifespan surprisingly do
not exist. For example, we have previously shown that heterozygous
(Sod2+/) mice with reduced levels of MnSOD, a mitochondrial
antioxidant enzyme, have compromised mitochondrial function but
no reduction in lifespan (Mansouri et al., 2006; Van Remmen et al.,
2003; Williams et al., 1998). In contrast, a study by Dell’agnello et al.
(2007) reported that mice lacking expression of the Surf1 gene,
which codes for the SURF1 assembly protein for complex IV (cy-
tochrome c oxidase, COX) of the electron transport chain (Zhu et al.,
1998), show a significant increase in mean lifespan despite a dra-
matic reduction in COX activity (Dell’agnello et al., 2007). These
studies support the concept that mitochondrial function and lifespan
are not causally linked.
In humans, the SURF1 mutation leads to COX deficiency
(>90%) in multiple tissues and causes a fatal neurological disorder,
Leigh syndrome (Tiranti et al., 1998). Mice lacking active SURF1
protein (Surf1/ mice) were developed to study Leigh Syndrome
(Dell’agnello et al., 2007). However, despite reduced COX activity
in all tissues, the Surf1/ mice exhibited an unexpected increase
in lifespan and a number of phenotypes that do not seem consis-
tent with reduced mitochondrial ETC activity. For example, Surf1/
 mice are protected from kainic acid-induced neuronal damage,
and isolated neurons from Surf1/ mice are resistant to cytotoxic
effects of glutamate (Dell’agnello et al., 2007). Studies from our
laboratory have shown that Surf1/ mice have reduced fat mass,
improved insulin sensitivity, and enhanced memory, compared to
wild-type (Surf1+/+) mice (Deepa et al., 2013; Lin et al., 2013). In
addition, tissues from Surf1/ mice show increased mitochondrial
biogenesis and induction of the mitochondrial unfolded protein
response (UPRmt), an evolutionarily conserved stress response
pathway (Baker, Tatsuta & Langer, 2011). Fibroblasts from Surf1/
 mice also show increased resistance to cellular stresses (Pharaoh
et al., 2016; Pulliam et al., 2014) suggesting that reduced COX
activity induces compensatory mitochondrial stress response path-
ways.
To better understand how the loss of a key mitochondrial pro-
tein and dramatically reduced ETC Complex IV activity can generate
the positive phenotypes listed above, we set out to critically assess
the effect of Surf1 deletion on lifespan in mice and to determine the
physiological changes in response to reduced mitochondrial ETC that
may contribute to increased lifespan. We repeated the lifespan anal-
ysis because (i) the original lifespan study was not intended to be an
aging study and did not measure maximum lifespan in all cohorts in
the study; (ii) the Surf1+/+ mice had a short lifespan relative to previ-
ously reported values for this strain (B6D2F1); and (iii) because diet-
ary restriction (DR) has been shown to increase lifespan, we were
interested in testing whether DR would further increase lifespan in
the Surf1/ mice. Our data confirm that the Surf1/ mice are able
to avoid a reduction in lifespan despite significant loss of COX activ-
ity. These data provide evidence that reduced mitochondrial ETC
activity is not a de facto negative determinant of lifespan, and one
cannot assume that all deficiencies in mitochondrial proteins will
translate to negative effects on lifespan.
2 | RESULTS
2.1 | COX activity is reduced in Surf1/ mice
Surf1 deficiency was previously reported to lead to a reduction in
COX activity, without affecting activity of other ETC complexes
(Dell’agnello et al., 2007; Pulliam et al., 2014). Here, we measured
COX activity in liver, heart, and white adipose tissue (WAT) of young
(8–12 months) and old (24–27 months) Surf1/ and Surf1+/+ female
mice using tissue homogenates. COX activity is reduced in all three
tissues ranging from 22% to 87% in young and old Surf1/ mice,
compared to Surf1+/+ mice on either an AL or DR diet (Figure 1 and
Table 1).
2.2 | Surf1/ mice lifespan and healthspan
We measured lifespan in Surf1+/+ and Surf1/ female mice fed an
AL or 40% DR diet (Figure 2a, Table 2). Surf1/ mice fed AL
showed a marginal increase in median lifespan (6.6%, p = .05) as well
as nonsignificant increases in mean (3.5%, p = .46) and maximal lifes-
pan (15.9% p = .72) compared to Surf1+/+ mice fed AL. DR robustly
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extended lifespan of both Surf1+/+ and Surf1/ mice, although to a
lesser extent in Surf1/ mice. Analysis of survival curves using the
Kaplan–Meier log-rank test showed no significant difference in the
survival of Surf1/ mice vs. Surf1+/+ mice fed AL (p = .44) or a DR
diet (p = .27), and confirmed the significant effect of the DR diet on
survival. Gompertz analysis of survival is shown in Figure 2b. The
Gompertz plot shows the log hazard function for each curve, mod-
eled as a linear function of age. Both genotypes fed a DR diet
showed a lower line slope, suggesting a slower age acceleration in
response to DR. However, no difference was observed between Sur-
f1+/+ and Surf1/ mice on either diet. Although both Kaplan–Meier
log-rank test and Gompertz analysis failed to show a statistically sig-
nificant change in lifespan between Surf1+/+ and Surf1/ mice, we
did detect small differences when we analyzed the difference in
quartile survival time, between pairs of curves, for all quartiles (Q).
Interestingly, Surf1/ mice fed AL showed a significant increase in
lifespan at Q.5 and Q.7, compared to Surf1+/+ mice fed AL and Sur-
f1/ mice fed a DR diet showed a significant decrease in lifespan at
Q.4 (p = 1.5 9 102) compared to Surf1+/+ mice fed a DR diet
(Table S1). Our findings show that deficiency of Surf1 does not
affect overall lifespan.
Lifespan is a valuable measure of the ultimate cumulative effects
of aging (Fischer et al., 2015). However, it has become increasingly
evident that changes in markers that indicate the overall general
health and vitality of an organism, that is healthspan, are also highly
informative (Richardson et al., 2016). To assess the effects of com-
plex IV deficiency in the Surf1/ mice on healthspan, we measured
several physiologic parameters including grip strength, rotarod per-
formance, sleep/wake patterns, spontaneous cage activity in 28-
month-old female mice and cardiovascular function in 20-month-old
female mice. We found no significant changes in any of these
parameters between Surf1+/+ and Surf1/ mice (Figure 3).
(a)
(b)
(c)
F IGURE 1 COX activity is reduced in Surf1/ mice fed AL or a
DR diet. COX activity in tissue homogenates of liver (a), heart (b),
and WAT (c) of Surf1+/+ (black bars) and Surf1/ mice (white bars)
fed AL or DR diet. Error bars represent mean  SEM (n = 4–7). *
Surf1+/+ -AL vs. Surf1/ -AL, + young vs. old; #AL vs. DR. */+/#
p < .05
TABLE 1 COX activity is reduced in Surf1/ mice fed AL or DR
diet. COX activity from Figure 1 represented as percentage decrease
in Surf1/ mice compared to Surf1+/+ mice
% Decrease in Surf1/ mice compared to Surf1+/+ mice
AL DR
Young Old Young Old
Liver 65.6  14.6 86.7  27.1 65.6  10.9 73.7  24.2
Heart 30.3  2.2 51.0  5.6 36.8  2.4 45.7  5.2
Fat 77.4  12.6 25.4  2.4 54.9  5.6 39.2  6.5
F IGURE 2 Surf1/ mice have increased median lifespan when
fed AL, and DR reduced median lifespan of Surf1/ mice. (a) The
Kaplan–Meier survival curves for Surf1+/+and Surf1/ female mice
fed AL and DR diet. The curves represent Surf1+/+ mice fed AL
(black circle, n = 29), Surf1/ mice fed AL (white circle, n = 32),
Surf1+/+ mice fed a DR diet (black square, n = 45), Surf1/ mice fed
a DR diet (white square, n = 44). (b) Gompertz plot for Surf1+/+and
Surf1/ female mice fed AL and DR diet
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2.3 | Surf1/ mice fed AL but not a DR diet have
a reduction in body weight and fat mass with age
Previously, we reported reduced fat mass and body weight in young
Surf1/ male mice compared to Surf1+/+ mice (Deepa et al., 2013).
We found a similar pattern in loss of fat mass in this study. At
800 days of age, Surf1/ mice have 25% reduction in body weight
compared to age-matched Surf1+/+ mice (Figure 4a). In mice fed DR,
Surf1+/+ and Surf1/ mice lost fat mass in a similar pattern (Fig-
ure 4b). Both genotypes on a DR diet showed similar changes in lean
mass with age, however, at 800 days of age, Surf1/ mice fed AL
have a 15% lower lean mass than age-matched Surf1+/+ mice fed AL
(Figure 4c).
2.4 | Tissue-specific differential regulation of
pathways and genes in Surf1/ mice
Microarray analysis was performed as an unbiased approach to com-
pare gene expression of liver, WAT, and brain (cortex) of Surf1+/+
and Surf1/ mice fed AL. We used a p < .05 cutoff to detect
expression of genes significantly altered by Surf1 deficiency. In liver
from Surf1/ mice, 714 transcripts showed a significant change
compared to Surf1+/+ mice: 336 genes were downregulated and 378
genes were upregulated (Figure 5a). In WAT of Surf1/ mice, 2,311
transcripts showed significant changes compared to Surf1+/+ mice:
1,179 genes were downregulated and 1,132 genes were upregu-
lated. In brain from Surf1/ mice, 318 transcripts showed significant
changes compared to Surf1+/+ mice, 119 genes were downregulated
and 199 genes were upregulated. However, none of the downregu-
lated genes were the same among the three tissues studied. In con-
trast, among the upregulated transcripts, ADAM Metallopeptidase
Domain 11 (Adam11) and Transmembrane and Coiled-Coil Domains
3 (Tmco3) were upregulated in all three tissues. Transcripts in liver
and WAT of Surf1/ mice showed an overlap: 36 of the downregu-
lated genes and 45 of the upregulated genes were similar in liver
and WAT. Similarly, 11 of the downregulated genes and 23 of the
upregulated genes in Surf1/ mice were similar in WAT and brain.
Comparison of transcripts in brain and liver showed that nine of the
genes are downregulated and two of the genes upregulated in both
brain and liver (Figure 5a).
Heatmap analysis of genes that showed a significant change
compared to Surf1+/+ mice is shown in Figure 5b. Using ingenuity
pathway analysis (IPA), we found that in liver, WAT, and brain 21,
95, and 30 pathways, respectively, are altered due to Surf1
deficiency. Figure 5c shows the top 5 canonical pathways that are
changed in liver, WAT, and brain of Surf1/ mice. Even though we
found significant changes in pathways in liver, WAT, and brain of
Surf1/ mice, there was no overlap between the pathways in the
three tissues. This suggests that Surf1 deficiency has a differential
effect on metabolism/signaling pathways in different tissues.
Table S2 shows the genes upregulated or downregulated in liver,
WAT, and brain of Surf1/ mice.
2.5 | Effect of diet and genotype on tissue
metabolites in Surf1/ mice
A total of 221 metabolites were analyzed in adipose tissue of Surf1+/+
and Surf1/ mice and of these 57 metabolites were increased and
46 metabolites were decreased (Table S3). Surf1 deficiency altered
the level of 28 metabolites in adipose tissue in mice fed an AL diet:
two were increased and the other 26 were decreased. Metabolites
that change in response to Surf1 deficiency belong to the following
metabolic pathways: amino acid (11 decreased); carbohydrate (two
increased); lipid (nine decreased and one increased); and nucleotide
(four decreased and one increased) (Table S3). In adipose tissue from
Surf1+/+ mice, 22 metabolites changed (eight increased and 14
decreased) and in Surf1/ mice 42 metabolites showed a significant
change (39 increased and three decreased). Thus, Surf1/ mice
showed a greater effect on metabolites in response to DR and the
greatest effect was observed in metabolites in the lipid metabolism
pathway (Table S3).
The liver tissue dataset is comprised of a total of 327 biochemi-
cals of which 47 showed a significant change (39 increased and eight
decreased) (Table S4). Several amino acids, including phenylalanine,
glycine, tryptophan, leucine, and valine, were present at higher levels
in Surf1/ mice livers, suggesting higher levels of protein turnover
in Surf1/ mice livers. A striking accumulation of medium-chain free
fatty acids—12:0, 10:0, 9:0, and 8:0—as well as the acylglycine con-
jugate valerylglycine are symptomatic of a block in the function of
the medium-chain acyl-CoA dehydrogenase (MCAD).
2.6 | Metabolic pathway analysis in adipose tissue
Previously, we found that deficiency of Surf1 in male mice shift
metabolism to increased fatty acid oxidation in peripheral tissues
(Deepa et al., 2013). Here, we used a targeted quantitative pro-
teomic approach to assess the changes in metabolic pathways in WAT.
We analyzed WAT from Surf1/ mice and Surf1+/+ mice fed AL and
TABLE 2 Lifespan analysis of Surf1+/+ and Surf1/ mice fed AL or DR diet. The survival data from Figure 2 are expressed in days. Mean,
median, 90% and maximum lifespan of Surf1/ mice are compared to Surf1+/+ mice in AL and DR groups
Surf1+/+ -AL Surf1/ -AL Surf1+/+ -DR Surf1/ -DR
Mean  SEM 797  27.7 825  21.5 1063  53.8 973  53.6
Median 794 850a 1,077 1,009
90% 999 972 1,352 1,288
Maximum 1,098 1,273 1,600 1,486
aIndicates significant difference between genotypes.
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DR diet less than 400 days of age to see changes prior to fat loss. Of
the 16 proteins analyzed in carbohydrate metabolism, only four pro-
teins showed a significant difference due to Surf1 deficiency, three
were downregulated (Hk1, Pygb, Taldo) and one was upregulated
(Ldhb). DR did not alter the expression of any of the proteins in the
carbohydrate metabolism panel in Surf1+/+ mice compared to AL-fed
Surf1+/+ mice, however, 14 proteins in Surf1/ mice are upregulated
due to DR, compared to AL-fed Surf1/ mice (Figure 6). DR also
showed a genotype-specific effect on protein expression: expression
of Akr1b1, Ldhb, Slc2a4, and Taldo is increased in Surf1/ mice fed
DR diet, compared to Surf1+/+ mice fed DR diet.
Protein expression analysis of a panel of 36 enzymes involved in
mitochondrial and peroxisomal fatty acid oxidation pathways
revealed no changes in Surf1/ mice fed an AL diet (Figure 6). Four
of the proteins in the fatty acid oxidation panel were upregulated in
Surf1+/+ mice and 15 are upregulated in Surf1/ mice on DR. Pex13
is the only protein that showed a significant increase in DR-fed Sur-
f1/ mice compared to DR-fed Surf1+/+ mice (Figure 6).
Analysis of a panel of 40 enzymes/proteins in tricarboxylic acid
cycle (TCA), electron transport chain (ETC), and mitochondrial
enzymes/proteins showed that protein expression of four proteins
was downregulated by Surf1 deficiency (Fis1, Opa1, Sdhc, and
Slc25a4) (Figure 6). Twenty of the 40 proteins analyzed in the
F IGURE 3 Surf1/ mice do not show changes in markers of
healthspan. (a) Grip strength measured in 28-month-old Surf1+/
+and Surf1/ female fed AL. The grip force (in grams) was
measured over 10 trials and the maximum force was recorded. (b)
Rotarod performance measurement in 28-month-old Surf1+/+ (black
bars) and Surf1/ (white bars) female fed AL. The average latency
to fall from the rod (in seconds) was recorded. (c) Sleep
fragmentation in 28-month-old Surf1+/+ (black bars) and Surf1/
(white bars) female fed AL expressed as the number of sleep
bouts per hour of sleep (any period of inactivity (no beam breaks)
greater than or equal to 40 s). (d) Spontaneous activity measured
in AL-fed 28-month-old Surf1+/+ (black bars) and Surf1/ (white
bars) mice measured as the number of beam breaks (e)
Cardiovascular functions end systolic dimension (left panel) and
fractional shortening (right panel) in 20-month-old Surf1+/+ (black
bars) and Surf1/ (white bars) female mice measured as
previously described (Pulliam et al., 2014). Error bars represent
mean  SEM
F IGURE 4 Surf1/ mice fed AL, not a DR diet, have a reduction
in body weight and fat mass with age. Change in body weight (a), fat
mass (b), and lean mass (c) with age in Surf1+/+ and Surf1/ mice in
the survival cohorts. The curves represent Surf1+/+ mice fed AL
(black circle), Surf1/ mice fed AL (white circle), Surf1+/+ mice fed a
DR diet (black square), Surf1/ mice fed a DR diet (white square).
Error bars represent mean  SEM
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F IGURE 5 Tissue-specific differential expression of genes and metabolic pathways in Surf1+/+ and Surf1/ mice. (a) Venn diagram showing
number of genes significantly downregulated (left panel) or upregulated (right panel) in liver (blue), WAT (yellow), and brain (green) using a
filtering criteria of p < .05. (b) Heatmap showing expression of all the significantly changed probes in liver (left panel), WAT (middle panel), and
brain (right panel). The Surf1+/+ and Surf1/ samples were clustered using average linkage hierarchical cluster with Euclidean distance using a
criteria of p < .05. Green represents downregulated genes and red represents upregulated genes. (c) The top five pathways from Ingenuity
Pathway Analysis ranked by the lowest p-values as determined by the Fisher’s exact test are shown for liver (left panel), WAT (middle panel),
and brain (right panel). The yellow line represents the -log of the p-value and the bolded number on the right side of the graph represents the
total number of possible genes of that pathway. Green color indicates percentage of downregulated genes, red color indicates percentage of
upregulated genes, and white color indicates the percentage not found in the significant gene list. Table S2 lists the genes identified by
Ingenuity Pathway Analysis
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mitochondrial panel were upregulated in Surf1/ mice on DR diet,
whereas only four proteins were upregulated in Surf1+/+ mice fed
the DR diet (Figure 6). Surf1/ mice fed DR diet showed downregu-
lation of four proteins (Fis1, Opa1, Sdhc, and Slc25a11) compared to
Surf1+/+ mice fed DR diet. Therefore, Fis1, Opa1, and Sdhc were
downregulated in Surf1/ independent of diet.
Among antioxidants, chaperones, heat shock proteins, and pro-
teases (a total of 33 proteins) in the stress response panel, absence
of Surf1 reduced the expression of 11 proteins in Surf1/ mice
compared to Surf1+/+ mice (Figure 6). DR increased the expression
of 25 proteins in Surf1/ mice fed DR vs. AL diet, whereas only five
proteins were elevated in Surf1+/+ mice fed DR diet. DR also showed
a genotype-specific effect on protein expression in the mitochondrial
panel: Gsr and Hspa1a were increased and catalase was decreased
in Surf1/ mice fed DR diet, compared to Surf1+/+ mice fed DR diet
(Figure 6, Table S5).
2.7 | UPRmt-associated proteins and mitochondrial
ETC complex subunits are induced transcriptionally in
Surf1/ mice liver, but not in heart
Because the effect of aging on the UPRmt has not been reported in
mice, we measured transcript and protein levels of UPRmt-associated
proteins ClpP, LonP1, and Hsp60 in young and old Surf1/ and
(a) (b) (c) (d)
F IGURE 6 Metabolic pathways are altered in Surf1/ mice adipose tissue and DR reverses most of these changes. Heatmaps representing
changes in protein expression of enzymes/proteins in Surf1/ mice compared to Surf1+/+ mice fed AL or DR in carbohydrate metabolism (a),
fatty acid metabolism (b), TCA cycle, ETC proteins, and assorted mitochondrial proteins (c), and stress response (d) in WAT obtained by
targeted mass spectrometry analysis. Blue indicates downregulated proteins, white is unchanged, and red is upregulated. A summary of the
data (e) represents number of enzymes/proteins in the pathway that are altered. Statistical significance determined by two-Way ANOVA with
Tukey’s post hoc test (n = 7–8)
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Surf1+/+ mice. In young Surf1/ mice liver, transcript levels of ClpP,
LonP1 are elevated by 1.4- and 2.9-fold, respectively, compared to
young Surf1+/+ mice (Figure S1a). However, an induction in mRNA
levels for UPRmt-associated proteins is not observed in Surf1/
mice heart (Figure S1b), suggesting a tissue-specific effect of UPRmt
in response to Surf1 deficiency. Our findings suggest that UPRmt-
associated proteins are induced only when the mice are young, not
old, and they also show a tissue-specific difference in their expres-
sion with age. The absence of UPRmt induction, assessed by the
transcript levels of UPRmt-associated proteins, in old Surf1/ mice
suggests that the UPRmt is not directly involved in lifespan exten-
sion. However, the effect of UPRmt induction at young age on lifes-
pan is not known.
Surf1/ male mice are reported to have elevated mitochondrial
biogenesis and increased expression of ETC subunits (Pulliam et al.,
2014). Here, assessment of transcript levels of ETC subunits in liver
of female Surf1/ and Surf1+/+ mice showed that transcript levels
of ETC subunits NDUFS3 (3.8-fold), ND1 (2.2-fold), SDHA (3.9-fold),
SDHB (3.2-fold), Reiske protein (3.5-fold), COX2 (2.3-fold), and
ATPase 6 (1.6-fold) were significantly elevated in young Surf1/
mice (Figure S1e). However, there was no significant difference in
the transcript levels of the ETC proteins in old Surf1/ mice liver,
compared to old Surf1+/+ mice (Figure S1e). In contrast to the
changes in ETC subunits in liver, ETC subunit mRNA levels were
similar in Surf1+/+and Surf1/ mice heart at young and old ages
(Figure S1f).
3 | DISCUSSION
The key finding of this study is that a 22%–87% reduction in activity
of a mitochondrial ETC complex (Complex IV) across all tissues mea-
sured does not significantly limit lifespan or negatively affect health-
span. Further, we show numerous and tissue-specific changes in
metabolism, protein, and gene expression in response to the loss of
Surf1. For many years, there has been a widely held hypothesis that
mitochondrial function decreases during aging and contributes to
aging and age-related physiologic decline. Specifically, the Mitochon-
drial Theory of Aging predicts that damage to the mitochondrial ETC
and mitochondrial DNA over time accumulates and contributes to a
spiral of compromised mitochondrial function that facilitates aging
(Harman, 1972). The data we present here do not support this
hypothesis. Rather, our results support the concept of a threshold
effect for loss of mitochondrial function and provide clear evidence
for a link between the ETC and metabolism.
Despite the commonly held concept that mitochondrial dysfunc-
tion is directly related to limited lifespan, the evidence available to
support this is not unequivocal. For example, reduced ETC activity
can lead to increased lifespan in C. elegans mitochondrial ETC (Mit)
mutants (Munkacsy & Rea, 2014). Specifically, RNAi knock-down of
genes encoding subunits of ETC complexes I, III, or IV, and mito-
chondrial enzyme CoQ7 (Clk-1) results in lifespan extension (Dillin
et al., 2002; Lee et al., 2003; Munkacsy & Rea, 2014). Similar to
the findings in C. elegans, inhibition of all ETC complexes, except
complex II, extended lifespan in flies (Copeland et al., 2009). These
studies in invertebrates are in clear contrast to the idea that mito-
chondrial function limits lifespan and the mechanisms responsible
have not been defined. In mice, the effect of compromised mito-
chondrial ETC on lifespan is varied. Mice heterozygous for the Mclk
gene, the homolog of the C. elegans clk1 gene (the first reported
long-lived mitochondrial mutant in C elegans), have an extended
lifespan (Lapointe, Stepanyan, Bigras & Hekimi, 2009), while Mclk
homozygous null mice show a dramatically shortened lifespan
(Hughes & Hekimi, 2011). Likewise, mice with a homozygous dele-
tion of an ETC complex I subunit (Ndufs4 knockout mice) also
show reduced longevity. Both of these mutant mouse models are
very short-lived and have severe respiratory and metabolic pheno-
types (Kruse et al., 2008; Wang, Oxer & Hekimi, 2015). One expla-
nation for the seemingly contradictory effects of ETC mutation and
longevity is a threshold effect in which compromised mitochondrial
function alters cellular function only once a critical deficiency in
ATP production in reached. In the context of mitochondrial muta-
tions that cause mitochondrial disease, the variable phenotypes that
occur have been tied to a critical threshold of mutation load (ap-
proximately 80%–90%) above which the phenotypes associated
with disease occur (Rossignol et al., 2003). For example, heterozy-
gous knock-in mice with reduced levels of DNA polymerase c, a
mitochondrial DNA proofreading enzyme, have a 30-fold increase
in mitochondrial DNA mutation load but show no deleterious phe-
notypes and have a normal lifespan while homozygous null mutants
have a dramatic reduction in lifespan (Vermulst et al., 2007). Using
cybrids containing a Complex I (ND5) mutation, Bai, Shakeley and
Attardi (2000) showed that reduced mitochondrial respiration
occurred only after the percentage of heteroplasmy reached 60%.
Likewise, other studies have shown that inhibition of ETC com-
plexes will not affect respiration or ATP production until a thresh-
old is exceeded. In fact, this biochemical threshold was shown to
be at 75% inhibition for COX in an in vitro analysis using isolated
muscle mitochondria in vitro (Letellier, Heinrich, Malgat & Mazat,
1994).
Consistent with the threshold concept, we tested mitochondrial
function in the Surf1/ mice using standard in vitro assays and
found no loss of mitochondrial function and no evidence for
increased ROS generation (Pulliam et al., 2014). It is possible that
this is somehow related to an increase in mitochondrial biogenesis
to compensate for the reduction in COX activity in tissues of the
Surf1/ mice and inhibit any pathophysiological consequences at
the cellular level. However, there is evidence that the mitochondria
in the Surf1/ mice are impaired to some extent in vivo. For exam-
ple, the Surf1/ mice have a significantly diminished treadmill
endurance capacity and elevated blood lactate, consistent with
impaired mitochondrial function (Pulliam et al., 2014).
The goal for this study was to determine the metabolic changes
that occur in vivo in response to the reduction in SURF1 and Com-
plex IV activity that might contribute to the increase in lifespan in
Surf1/ mice originally reported by Dell’agnello et al. (2007). We
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were also interested in whether DR could extend this lifespan exten-
sion. Thus, we repeated the lifespan study in female mice under AL
and DR (40% restriction) conditions. However, our lifespan analysis
revealed only a slight and nonsignificant increase (7%) in median
lifespan, compared to the 17% increase previously reported for
female Surf1/ mice. Despite the discrepancy in the survival results,
the critical fact remains that we did not see compromised lifespan
despite the severe reduction in complex IV activity. This is not the
first time a study was unable to replicate the increase in lifespan
shown in an original study. For example, knockout mouse models for
the signaling molecule p66Shc (p66shc/ mice) (Migliaccio et al.,
1999), insulin receptor substrate 2 (Irs2) (Irs2+/ mice) (Taguchi,
Wartschow & White, 2007), and the IGF1 receptor (Igf1r+/ mice)
(Holzenberger et al., 2003) all showed substantial lifespan extension
in initial reports that was not confirmed in follow-up studies (Bokov
et al., 2011; Ladiges et al., 2009; Liang et al., 2003; Ramsey et al.,
2014; Selman, Lingard, Gems, Partridge & Withers, 2008; Selman
et al., 2007; Unnikrishnan, Deepa, Herd & Richardson, 2017). Differ-
ences in genetic background can potentially modulate lifespan
results. However, this was not a contributing factor in our results as
the mice in our study and the study by Dell’agnello were on the
same genetic background (B6D2F1/J). In contrast, a key difference
between the lifespan results in the Surf1/ mice lifespan study by
Dell’agnello et al. (2007) and our study is the mean lifespan of the
Surf1+/+ mice. They reported a mean lifespan of 700 days for female
Surf1+/+ mice. This is considerably lower than previously reported for
female Surf1+/+ mice on B6D2F1/J background, that is, a mean lifes-
pan 826 days (Yamate, Tajima, Kudow & Sannai, 1990). Hence, it is
possible that the reduced lifespan of Surf1+/+ mice contributed to
the observed lifespan extension in Surf1/ mice. The Surf1+/+ mice
in our cohort show a mean lifespan consistent with previously
reported values (797 days), while the Surf1/ mice in our cohort
had a mean survival of 825 days. Interestingly, this is very close to
the lifespan originally reported by Dell’agnello et al. (2007)
(820 days), further supporting the possibility that the reduced Sur-
f1+/+ lifespan contributed to the lifespan extension they reported.
We found that DR extended lifespan in both Surf1+/+ and Surf1/
mice; however, the effect was surprisingly less in the Surf1/ mice
(18% and 17% extension in mean and maximum lifespan, respec-
tively, in the Surf1/ mice vs. a 33% and 46% extension in Surf1+/+
mice). Our metabolic and phenotypic data unfortunately do not
reveal a plausible explanation for the reduced response of the Sur-
f1/ mice to DR, but one hypothesis might be that mitochondrial
function may be more adversely affected by lower nutrient flux in
response to DR in the mice with compromised COX activity.
Our previous studies in young adult male Surf1/ mice showed
interesting metabolic phenotypes such as reduced fat mass,
increased insulin sensitivity, and increased mitochondrial biogenesis
in some tissues. There was also an induction of the mitochondrial
unfolded protein response (UPRmt) in several tissues, suggesting
that the misassembly of Complex IV subunits due to the lack of
the SURF1 assembly factor might induce upregulation of proteosta-
sis and other protective mechanisms that may be related to the
increase in lifespan. In the current study, we did not find a clear
induction of the UPRmt. One possible reason for this is that our
original studies were performed using male mice and the current
study is in female mice. We also did not find a clear relationship
between the UPRmt and aging in this study. In addition, the most
consistent finding in all the metabolic data we collected is the fact
that COX deficiency affects gene expression metabolites and meta-
bolic pathways in a tissue-specific manner. Likewise, DR shows tis-
sue-specific effects on proteins and metabolites in Surf1+/+ and
Surf1/ mice. In the current study, our metabolic studies mainly
focused on adipose tissue, liver and, brain. Adipose tissue and liver
play a role in metabolism, and the Surf1/ mice tend to have less
fat and improved insulin sensitivity (Deepa et al., 2013). We mea-
sured changes in brain, because many genetic manipulations
restricted to brain have been shown to affect lifespan. For example,
there is a report showing that a CNS-restricted knockout of Surf1
can extend lifespan in fruit flies (Zordan et al., 2006). Adipose tis-
sue had by far the most changes in gene expression. Over 2,000
genes were differentially regulated in adipose tissue between Sur-
f1+/+ and Surf1/ mice. These changes may be related to the dra-
matic loss of fat mass that occurs in the Surf1/ mice over their
lifespan. Metabolomic analysis in adipose tissue showed 28 of 221
metabolites were different between the Surf1+/+ and knockout mice
on AL diet but only half as many (11 metabolites) differed in Sur-
f1+/+ vs. Surf1/ mice on DR. This may be related to the fact that
there is no differential loss of fat mass in the Surf1/ mice on DR
and may also be related to the reduced lifespan extension in the
Surf1/ mice on DR compared to Surf1+/+ mice on DR. In sum-
mary, the most important finding in this study is that reduced com-
plex IV activity throughout the lifespan does not negatively impact
lifespan or healthspan. The long held idea that mitochondrial dys-
function is a negative determinant of aging should be tempered by
the idea that not all mitochondrial impairments do not accelerate
aging or physiologic decline and may in fact have hidden beneficial
effects on metabolism.
4 | EXPERIMENTAL PROCEDURES
4.1 | Animals and lifespan
Surf1/ mice were generated as described by Dell’agnello et al.
(2007). Experiments were conducted in female Surf1/ B6D2F1/J
(C57BL/6J_DBA/2) mice and control littermates (Surf1+/+), unless
otherwise stated, and were performed according to the protocol
approved by the IACUC at the University of Texas Health Science at
San Antonio. Mice for the lifespan study were generated by crossing
Surf1+/ mice to each other to obtain Surf1/ and Surf1+/+ mice
and only females were used for the study. For the lifespan study
using AL-fed mice, we used 32 Surf1/ mice and 29 Surf1+/+, and
for the dietary restricted lifespan study, 44 Surf1/ mice and 45
Surf1+/+were used. Mice (5 animals/cage) were housed under barrier
conditions using micro-isolator cages and were fed AL a standard
NIH-31 chow diet (Harlan Teklad, Madison, WI, USA) on a 12-h
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dark-light cycle. Dietary restriction was initiated at 2 months of age
by feeding DR mice 60% of the diet (by weight, 40% restriction)
consumed by the mice fed AL. For the lifespan experiments for mice
AL or a DR diet, the mice were allowed to live out their natural lifes-
pan and lifespans for mice were determined by recording the ages
of spontaneous death of the mice. The mean, median, 10% (the
mean lifespan of the longest-lived 10% of animals), and maximum
(the age of death for the longest-lived mouse in the cohort) lifespans
were calculated from the survival data for each group. Body compo-
sition of the mice was determined monthly by quantitative magnetic
resonance (QMR, Echo Medial Systems, Houston, TX, USA). Food
consumption was measured for a one week period every two weeks
for 3 months and monthly for 11 months in 19-20 mice (four cages)
per genotype. There was no difference in food consumption
between the Surf1+/+ and Surf1/ mice. Surf1/ mice consumed
3.1 g  0.1 g per day and Surf1+/+ mice consumed 3.0  0.0 g per
day).
4.2 | COX activity assay
COX activity was measured in liver, heart, and WAT homogenates
as described (Spinazzi, Casarin, Pertegato, Salviati & Angelini, 2012).
The rate of oxidation of cytochrome c was calculated from the
change in absorbance at 550 nm. The extinction coefficient of
21.84/mM/cm was used to determine the enzymatic activity.
4.3 | Microarray analysis
Microarray processing was carried out at the National Institute on
Aging, Gene Expression and Genomics Unit as previously described
(Fok et al., 2014).
4.4 | Metabolomics
Frozen brain tissue (n = 8) and WAT (n = 8) were analyzed for
metabolite levels by Metabolon (Durham, NC, USA). At the time of
analysis, samples were extracted and prepared for analysis using
Metabolon’s standard solvent extraction method as previously
described (Ghazalpour et al., 2014). Data were normalized by Meta-
bolon and statistical analysis was performed using ANOVA with pair-
wise comparisons. False discovery analysis was then applied to the
dataset using R package “q value” (v 1.30.0, Dabney, A and Storey,
J). Metabolon imputed the data for metabolites that had samples
that were not detected using the lowest detected data value avail-
able for that metabolite. We excluded all metabolites that had
imputed value >20% in the groups we analyzed for the pairwise
comparisons. Statistical significance was indicated at q value < 0.05
and fold change >15%.
4.5 | Targeted quantitative proteomics
Selected reaction monitoring (SRM) mass spectrometry was used to
quantify protein abundance as described before (Kinter et al., 2012).
Bovine serum albumin (8 pmol) was added to 60 lg (as total protein)
of WAT tissue homogenate as an internal standard.
4.6 | Rotarod
Rotarod performance was measured as described by previously using
Rotamex 4/8 (Columbus Instruments, Columbus, OH, USA) (Muller
et al., 2006).
4.7 | Grip strength
Hindlimb muscle strength was determined by measuring peak force
using the Digital Grip Strength meter equipped with a Hind Limb
Pull Bar Assembly (Columbus Instruments, Columbus, OH, USA)
essentially as described before (Zhang et al., 2014). The grip force
was observed over 10 trials and the maximum force was recorded.
4.8 | Activity and sleep
Spontaneous activity and sleep were measured as previously
described (Fischer et al., 2016). Activity is measured in the number
of beam breaks. Sleep is measured using a method validated by Pack
et al. (2007). A sleep bout is any period of inactivity (no beam
breaks) greater than or equal to 40 s. Sleep fragmentation is charac-
terized by measuring the number of sleep bouts per hour of sleep.
Data were collected during the light and dark phase over the testing
period following acclimation (24-hr, one light and one dark phase)
(Pack et al., 2007).
4.9 | Statistical analyses
In general, a two-Way ANOVA with Tukey’s post hoc test was per-
formed using GRAPHPAD PRISM version 7.0b (GraphPad Software, La
Jolla California). Specific statistical analyses for individual datasets
are included in the Figure Legends. Kaplan–Meier estimation, Gom-
pertz parametric modeling, log-rank testing for differences between
survival curves, and Boschloo testing for difference in extreme sur-
vival were performed with specific functions implemented in the R
packages survival, eha and Exact. Quantile regression implemented
in the R package quantreg was used to estimate and compare mean,
median, and extreme quartile survival times for each group.
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